The International Myeloma Foundation is dedicated to improving the lives of multiple myeloma patients while working toward
prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
The International Myeloma Foundation (IMF) is harnessing the power of myeloma patients, their families, and the myeloma community at large to raise awareness of the disease during Myeloma Action Month (MAM), starting March 1, 2019. In 2009, the IMF was the first organization to declare March as Myeloma Awareness Month. The organization elevated the campaign in 2016 to Myeloma Action Month to encourage a more dynamic, proactive approach.
Join our Living Well teleconference to hear the latest updates from Dr. Brian GM Durie. This teleconference will provide an overview of Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma, and Newly Diagnosed myeloma patients.
We are thrilled to announce that on April 2, 2019, the Vrije Universiteit Brussel (VUB) will award a joint honorary doctorate for scientific excellence to Susie Durie, IMF President and Co-founder, and Brian G.M. Durie, MD, IMF Chairman and Co-founder, at a ceremony in Brussels, Belgium.
Reports from the frontlines of drug development—from selinexor to daratumumab—have dominated myeloma news recently. IMF Chairman Dr. Brian G.M. Durie explains what it all means for myeloma patients. He also takes a look at the week’s top environmental-impact stories.
In this week’s video, Dr. Brian G.M. Durie discusses gene editing research taking place that could affect the future of myeloma treatment options.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
